Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study

机译：每天一次USL255作为部分发作的辅助治疗：随机III期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo evaluate the efficacy and safety of USL255, Qudexy™ XR (topiramate) extended-release capsules, as an adjunctive treatment for refractory partial-onset seizures (POS) in adults taking one to three concomitant antiepileptic drugs.

机译：目的为了评估USL255 Qudexy™XR（托吡酯）缓释胶囊的疗效和安全性，该药物可作为成年人服用一到三种抗癫痫药的难治性部分发作（POS）的辅助治疗方法。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
Steve S Chung; Toufic A Fakhoury; R Edward Hogan; Venkatesh N Nagaraddi; Ilan Blatt; Balduin Lawson; Stephan Arnold; Bob Anders; Annie M Clark; Dawn Laine; R Shawn Meadows; Mark B Halvorsen;
展开▼
作者单位

展开▼
年(卷),期 -1(55),7
年度 -1
页码 1077–1087
总页数 11
原文格式 PDF
正文语种
中图分类
关键词
Epilepsy Topiramate Antiepileptic drug Extended release;

机译：癫痫;托吡酯;抗癫痫药;缓释;
入库时间 2022-08-21 11:04:09

相似文献

外文文献
中文文献
专利

1. Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study [J] . ChungS.S., FakhouryT.A., HoganR.E., Epilepsia: Journal of the International League against Epilepsy . 2014,第7期

机译：每天一次USL255作为部分发作的辅助治疗：随机III期研究
2. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. [J] . Elger C, Halasz P, Maia J Epilepsia: Journal of the International League against Epilepsy . 2009,第3期

机译：醋酸依西卡西平作为难治性部分发作的成人辅助治疗的有效性和安全性：一项随机，双盲，安慰剂对照，平行组III期研究。
3. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial. [J] . Peltola J, Coetzee C, Jimenez F Epilepsia: Journal of the International League against Epilepsy . 2009,第3期

机译：每日延长释放救生虫作为癫痫患者部分发作癫痫发作的辅助治疗：双盲，随机，安慰剂对照试验。
4. Once-daily Nadroparin Versus Twice-daily Nadroparin in the Treatment of Patients with Acute Coronary Syndromes: The SAFRAX Study [C] . V. Hricak, A. Leizorovic International Congress on Thrombosis . 2006

机译：每日一日奈多林与每次每日Nadroparin治疗患者急性冠状动脉综合征患者：Safrax研究
5. Short-term (3-Month) Clinical Outcomes of WaterLase (iPlus) Laser Therapy used as an Adjunct to Non-Surgical Treatment of Chronic Periodontitis: A Randomized, Controlled, Within-Mouth Clinical Study. [D] . Raz, Galya. 2016

机译：WaterLase（iPlus）激光疗法作为慢性牙周炎非手术治疗的辅助手段的短期（3个月）临床结果：一项随机，对照，口内临床研究。
6. Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III double-blind randomized placebo-controlled trial [O] . Michael R Sperling, Bassel Abou-Khalil, Jay Harvey, -1

机译：醋酸依西卡西平治疗部分发作不全的患者的辅助治疗：III期双盲随机安慰剂对照试验的结果
7. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study [O] . Christian Elger, Peter Halász, Joana Maia, 2009

机译：EslicarBazepine醋酸乳碱的疗效和安全性作为难治性局部发作癫痫发作的成人辅助治疗：随机，双盲，安慰剂控制，平行组III研究

Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study

摘要

著录项

相似文献

相关主题

期刊订阅